Sandesh Mahatme
2012
In 2012, Sandesh Mahatme earned a total compensation of $4.8M as Senior Vice President, Chief Financial Officer at Sarepta Therapeutics.
Compensation breakdown
| Bonus | $130,000 |
|---|---|
| Non-Equity Incentive Plan | $37,570 |
| Option Awards | $4,600,950 |
| Salary | $67,836 |
| Other | $598 |
| Total | $4,836,954 |
Mahatme received $4.6M in option awards, accounting for 95% of the total pay in 2012.
Mahatme also received $130K in bonus, $37.6K in non-equity incentive plan, $67.8K in salary and $598 in other compensation.
Rankings
In 2012, Sandesh Mahatme's compensation ranked 1,265th out of 11,487 executives tracked by ExecPay. In other words, Mahatme earned more than 89.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,265 out of 11,487 | 89th |
Division Manufacturing | 453 out of 4,252 | 89th |
Major group Chemicals And Allied Products | 101 out of 1,200 | 92nd |
Industry group Drugs | 57 out of 922 | 94th |
Industry Pharmaceutical Preparations | 49 out of 697 | 93rd |
Source: SEC filing on April 30, 2015.
Mahatme's colleagues
We found seven more compensation records of executives who worked with Sandesh Mahatme at Sarepta Therapeutics in 2012.
2012
David Howton
Sarepta Therapeutics
General Counsel
2012
David Howton
Sarepta Therapeutics
General Counsel
2012
Christopher Garabedian
Sarepta Therapeutics
Chief Executive Officer
2012
Edward Kaye
Sarepta Therapeutics
Chief Executive Officer
2012
Michael Jacobsen
Sarepta Therapeutics
Vice President, Finance
2012
Jayant Aphale
Sarepta Therapeutics
Senior Vice President, Technical Operations
2012
Effie Toshav
Sarepta Therapeutics